JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Radde, I. C.
Right arrow Articles by Kalow, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Radde, I. C.
Right arrow Articles by Kalow, W.
Journal of Pharmacology And Experimental Therapeutics, Vol. 130, Issue 4, 436-443, 1960
Copyright © 1960 by American Society for Pharmacology and Experimental Therapeutics


SOME ASPECTS OF THYROID FUNCTION IN RATS AFTER FEEDING OF LEVOMEPROMAZINE

Ingeborg C. Radde 1 and Werner Kalow 1

1 Department of Pharmacology, University of Toronto, Toronto, Canada

Rats fed levomepromazine for varying periods of time showed a significant growth depression. Otherwise, treated rats looked healthy and were indistinguishable in appearance from their controls.

An analysis of variance of relative thyroid weights showed treated animals to have smaller thyroids than their respective controls. This depression of thyroid size increased with the duration of treatment.

The proportion of beta cells in pituitaries was decreased in animals treated for 14 and 42 days. The proportion of alpha cells in the glands was increased in treated rats.

Rats fed levomepromazine had a decreased content of radioactive iodine and/or hormones in their thyroids 24 hours following tracer administration. The analysis of variance of these data showed that the thyroid-depressing effect of the drug increased with the duration between tracer injection and sacrifice and that the drug influenced the I131 content of the gland by more than one mechanism.

Plasma as well as kidney radioactivity was significantly lower in treated than in control animals.

It was concluded that the decrease in radio-activity in thyroid glands of treated animals was due to a combination of accelerated excretion of iodide through the kidney and of decreased stimulation of the thyroid gland by the pituitary.

Submitted on May 8, 1960







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1960 by the American Society for Pharmacology and Experimental Therapeutics.